According to our (Global Info Research) latest study, the global Continuous Subcutaneous Insulin Infusion (CSII) Pump market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Insulin pump is an effective means of blood sugar management for diabetic patients. It is a micro-precise, continuously controllable subcutaneous insulin injection tool that can better simulate the physiological insulin secretion pattern. Obtaining the basis for adjusting the dose of insulin pump therapy through blood glucose monitoring is particularly important for diabetic patients characterized by endogenous insulin deficiency. The continuous glucose monitoring (CGM) system can facilitate continuous monitoring of blood glucose and thereby adjust the infusion dosage of the insulin pump.
Compared to a syringe or pen, an insulin pump provides a smooth and continuous infusion to maintain blood sugar stability throughout the day. CGM and insulin pump are two very important technologies in the diagnosis and treatment of diabetes today. They are often used together in clinical practice, called CGM&CSII therapy. The development of "double C" technology promotes the advancement of diabetes diagnosis and treatment technology.
This report is a detailed and comprehensive analysis for global Continuous Subcutaneous Insulin Infusion (CSII) Pump market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Continuous Subcutaneous Insulin Infusion (CSII) Pump market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Continuous Subcutaneous Insulin Infusion (CSII) Pump market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Continuous Subcutaneous Insulin Infusion (CSII) Pump market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Continuous Subcutaneous Insulin Infusion (CSII) Pump market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Continuous Subcutaneous Insulin Infusion (CSII) Pump
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Continuous Subcutaneous Insulin Infusion (CSII) Pump market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Tandem Diabetes Care, Insulet, SOOIL, LenoMed Medical, Omnipod, Roche, Royal Fornia Medical Equipment, Beijing Maishitong Technology, Shanghai MicroPort Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Continuous Subcutaneous Insulin Infusion (CSII) Pump market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Tethered Pump
Patch Pump (Micro Pump)
Market segment by Application
Type I Diabetes
Type II Diabetes
Others
Major players covered
Medtronic
Tandem Diabetes Care
Insulet
SOOIL
LenoMed Medical
Omnipod
Roche
Royal Fornia Medical Equipment
Beijing Maishitong Technology
Shanghai MicroPort Medical
Wuxi Apex Medical
Microtech Medical
Phray Medical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Continuous Subcutaneous Insulin Infusion (CSII) Pump product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Continuous Subcutaneous Insulin Infusion (CSII) Pump, with price, sales quantity, revenue, and global market share of Continuous Subcutaneous Insulin Infusion (CSII) Pump from 2020 to 2025.
Chapter 3, the Continuous Subcutaneous Insulin Infusion (CSII) Pump competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Continuous Subcutaneous Insulin Infusion (CSII) Pump breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Continuous Subcutaneous Insulin Infusion (CSII) Pump market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Continuous Subcutaneous Insulin Infusion (CSII) Pump.
Chapter 14 and 15, to describe Continuous Subcutaneous Insulin Infusion (CSII) Pump sales channel, distributors, customers, research findings and conclusion.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook